---
title: "Rossari Biotech Ltd (ROSSARI) — Share Price, Financials & Analysis"
symbol: "ROSSARI"
company: "Rossari Biotech Ltd"
canonical: "https://tapetide.com/stocks/ROSSARI"
isin: "INE02A801020"
nse_symbol: "ROSSARI"
bse_code: "543213"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 2456.62
generated_at: "2026-09-13T19:36:00.538Z"
---

# Rossari Biotech Ltd (ROSSARI)

Canonical page: https://tapetide.com/stocks/ROSSARI

## Company

- **NSE Symbol:** ROSSARI
- **BSE Code:** 543213
- **ISIN:** INE02A801020
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2020-07-23
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** rossari.com

## About

Rossari Biotech was started in 2003. 
They are among the largest manufacturers 
of textile specialty chemicals in India.[1]

## Latest Price

- **Price:** ₹446.15
- **Change:** -3.35 (-0.75%)
- **Open:** ₹449.65
- **Day High:** ₹449.65
- **Day Low:** ₹440.85
- **Previous Close:** ₹449.5
- **Volume:** 36449
- **As Of:** 2026-09-11T10:25:22+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:21.827472Z.

- **Market Cap:** ₹2456.62 Cr
- **Classification:** Microcap
- **P/E (reported):** 16.6
- **P/E (TTM):** 16.39
- **EPS (TTM):** ₹27.22
- **EPS (reported):** ₹24.68
- **Book Value:** ₹240.7
- **Price to Book:** 1.87
- **Dividend Yield:** 0.11%
- **ROE:** 11.19%
- **ROCE:** 15.41%
- **Debt to Equity:** 0.33
- **Revenue (yearly):** ₹2418.7 Cr
- **Net Income:** ₹149.2 Cr
- **EBITDA:** ₹308.3 Cr
- **52-Week High:** ₹690.3
- **52-Week Low:** ₹375
- **RSI (14):** 26.3

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 44.52 | 9% |
| growth | 71.31 | 9% |
| momentum | 29.71 | 12% |
| ownership | 22.14 | 24% |
| quality | 45.55 | 22% |
| valuation | 42.71 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's working capital requirements have reduced from 62.4 days to 48.6 days

### Weaknesses

- Company has a low return on equity of 12.0% over last 3 years.
- Dividend payout has been low at 2.00% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -52.66% | 50.42% | 121.63% |
| ebitda margin growth | -12.91% | -1.24% | -8.86% | -2.45% |
| net income growth | -23.7% | 9.38% | 8% | 11% |
| revenue growth | -0.51% | 16.04% | 13% | 28% |
| roce | -19.99% | 3.22% | -10.25% | 15.87% |
| roe | -23.65% | -2.7% | 11.72% | -7.75% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 | 685 | 697 |
| Expenses | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 | 617 |
| Operating Profit | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 | 77 | 81 |
| OPM % | 13 | 14 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 11 | 12 |
| Other Income | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 | 4 |
| Interest | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 |
| Depreciation | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 | 26 |
| Profit before tax | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 | 48 |
| Tax % | 26 | 28 | 25 | 26 | 27 | 25 | 28 | 27 | 26 | 23 | 28 | 26 |
| Net Profit | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 | 46 | 35 |
| EPS in Rs | 5.97 | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.3 | 6.34 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 516 | 600 | 709 | 1483 | 1656 | 1831 | 2080 | 2396 | 2550 |
| Expenses | 438 | 495 | 586 | 1299 | 1433 | 1581 | 1815 | 2110 | 2251 |
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 286 | 299 |
| OPM % | 15 | 17 | 17 | 12 | 13 | 14 | 13 | 12 | 12 |
| Other Income | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 24 | 26 |
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 | 34 |
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 | 87 |
| Profit before tax | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 | 204 |
| Tax % | 28 | 26 | 25 | 28 | 26 | 26 | 26 | 26 | — |
| Net Profit | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 149 | 151 |
| EPS in Rs | 103.82 | 12.86 | 15.45 | 17.74 | 19.45 | 23.66 | 24.63 | 26.94 | 27.22 |
| Dividend Payout % | 0 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 119 | 277 | 398 | 794 | 904 | 1037 | 1174 | 1322 |
| Borrowings | 8 | 67 | 0 | 8 | 74 | 119 | 218 | 436 |
| Other Liabilities | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 505 |
| Total Liabilities | 250 | 471 | 561 | 1255 | 1364 | 1567 | 1886 | 2274 |
| Fixed Assets | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 784 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 173 |
| Investments | 0 | 18 | 0 | 36 | 51 | 63 | 84 | 62 |
| Other Assets | 173 | 338 | 379 | 611 | 712 | 880 | 1063 | 1254 |
| Total Assets | 250 | 471 | 561 | 1255 | 1364 | 1567 | 1886 | 2274 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
| Cash from Investing Activity | -37 | -190 | -37 | -299 | -181 | -103 | -183 | -220 |
| Cash from Financing Activity | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 | 31 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 | -175 |
| CFO/OP | 118 | 74 | 64 | 43 | 89 | 39 | 74 | 47 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 61 | 57 | 74 | 75 | 78 | 85 | 83 | 85 |
| Inventory Days | 59 | 57 | 75 | 63 | 59 | 80 | 90 | 88 |
| Days Payable | 114 | 95 | 104 | 61 | 56 | 62 | 73 | 71 |
| Cash Conversion Cycle | 6 | 19 | 46 | 76 | 80 | 103 | 101 | 103 |
| Working Capital Days | 23 | 22 | 60 | 62 | 49 | 70 | 69 | 49 |
| ROCE % | — | 38 | 29 | 24 | 18 | 18 | 16 | 13 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 68.35% | 68.33% | 68.32% | 68.32% | 68.27% | 68.19% | 68.18% | 68.17% | 68.17% | 68.16% | 68.15% | 68.14% |
| FIIs | 5.74% | 4.14% | 4.03% | 3.83% | 3.74% | 3.74% | 3.98% | 3.48% | 2.69% | 2.33% | 2.18% | 2.02% |
| DIIs | 17.68% | 18.02% | 17.75% | 16.87% | 17.34% | 17.47% | 17.59% | 17.84% | 18.18% | 18.26% | 18.2% | 14.64% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 7.53% | 8.76% | 9.14% | 9.96% | 9.57% | 9.51% | 9.2% | 9.44% | 9.47% | 9.89% | 10.11% | 13.39% |
| Others | 0.71% | 0.75% | 0.76% | 1.02% | 1.09% | 1.09% | 1.05% | 1.07% | 1.48% | 1.37% | 1.35% | 1.8% |
| No. of Shareholders | 95200 | 100423 | 98859 | 100475 | 97188 | 95735 | 92852 | 91791 | 91387 | 89249 | 86972 | 87580 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 461.6 | Sell |
| EMA (10) | 461.72 | Sell |
| SMA (20) | 480.78 | Sell |
| EMA (20) | 475.09 | Sell |
| SMA (50) | 500.65 | Sell |
| EMA (50) | 492.78 | Sell |
| SMA (100) | 509.03 | Sell |
| EMA (100) | 503.12 | Sell |
| SMA (200) | 514.74 | Sell |
| EMA (200) | 526.47 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 25.14 | Buy |
| MACD (12,26,9) | -15.61 | Sell |
| Stochastic (14,3,3) | 4.23 | Buy |
| ADX (14) | 23.48 | Neutral |
| Williams %R (14) | -91.99 | Buy |
| ATR (14) | 13.42 | High Volatility |
| ROC (12) | -10.78 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 26.25 | Buy |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 75% |
| Hold | 1 | 25% |
| Sell | 0 | 0% |

Based on 4 analyst ratings, observed at 2026-09-11T04:47:20.324668+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2b17a95-468f-4b68-b91b-d596413803e7.pdf) |
| 2026-08-06 | [Update On Investor Call.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c826310e-36a7-48bf-9b58-e90a1f7a5d19.pdf) |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5084ffce-eca0-4d85-912f-c19bea5313ba.pdf) |
| 2026-07-20 | [Update On Grant Of Options.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0825e75-90ff-4f30-a252-5093a13a2a4d.pdf) |
| 2026-07-20 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=835195e0-110a-4636-8f91-c88f6c6f8265.pdf) |
| 2026-07-20 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bc6324f-acc9-401c-82ce-93a675591474.pdf) |
| 2026-07-19 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7c7850-f5ed-4180-9aa8-f10d5f60256c.pdf) |
| 2026-07-19 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4ff058e-6db1-42ff-9fb8-b3392ce04411.pdf) |
| 2026-07-18 | [Board Meeting Outcome for Outcome Of Board Meeting Held On July 18 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=966195df-a901-4875-990b-9ec928807435.pdf) |
| 2026-07-18 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c932b44f-ac8b-4d7c-9612-bc45d319f2f4.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28218f4f-820d-4788-842b-65543e779ecf.pdf) |
| 2026-05-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c378823-f001-4635-bf0e-d7b52bf3e703.pdf) |
| 2026-01-23 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf47fd1-c97d-4b4a-9207-336c0cd9f82d.pdf) |
| 2025-10-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e817dc3-1737-4f6e-82e1-e8c573f5d0c9.pdf) |
| 2025-07-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f331ad5b-c905-4ace-a715-baa359eaf89e.pdf) |
| 2025-05-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf) |
| 2025-01-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ac5ec2-5424-4c13-8fcd-ef9ccc9392b2.pdf) |
| 2024-10-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d96ddf06-d3a0-4cdf-ae1c-985798225f79.pdf) |
| 2024-07-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f5e4e94-fbca-40f6-84f4-8dd463e78e6b.pdf) |
| 2024-05-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09d45a5b-ddda-4f0c-8d04-692fc1d63370.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8110371b-4c03-4fe7-ae4b-63e089683bac.pdf) |
| 2026-04-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d112a84e-4cab-4b90-adac-a1483e06f8b7.pdf) |
| 2026-01-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a511da7-4d9d-4886-8500-9663de853d0f.pdf) |
| 2025-10-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8f5a873-747c-45b1-9e12-38b79f522d3b.pdf) |
| 2025-07-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4e76f5-59ee-4555-8dd3-5b2cbdd55b79.pdf) |
| 2025-04-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78a577eb-6caa-4141-b815-f4fbd32d0dfc.pdf) |
| 2024-10-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da4888dd-d239-486b-8364-e421a281edde.pdf) |
| 2024-07-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc0a5538-9729-43ba-80b9-69c276c5cb32.pdf) |
| 2024-04-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45d8337c-62e5-4921-ac92-566d977a2a6e.pdf) |
| 2024-01-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cdb2724-8f6f-4a52-b1b7-1931bae81530.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f46457b9-3256-40b8-8a95-605e5c0b7600.pdf) |
| 2026-04-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=940dde22-2876-411b-a8ed-a603f6e4c735.pdf) |
| 2026-01-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845f5929-f435-44d2-97f8-efe265495347.pdf) |
| 2025-10-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26fcb99d-61d3-49d9-984b-a58a424b9bd6.pdf) |
| 2025-07-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90423203-077e-4f63-a104-2b207631ed5b.pdf) |
| 2025-04-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=117b9536-8cbe-46a8-98fc-1974e72d1db7.pdf) |
| 2025-01-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=484acb2b-b9ba-41a9-afbf-dcc6a9aef183.pdf) |
| 2024-10-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5e3d388-a15c-498b-9427-5418b7252be6.pdf) |
| 2024-10-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fae57ef-62dd-4c3a-a2ce-e48b30d8f5e9.pdf) |
| 2024-07-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e850e40b-0c79-405b-afed-9ac0701cc3a7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-18 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604d53f4-3f0c-4adb-8b59-9358a0813024.pdf) |
| 2026-04-27 | [Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0c2fbda-3591-44be-95a0-87a2ab324d48.pdf) |
| 2026-01-17 | [Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9bf25a3-e618-4935-831b-3ad703a06e5f.pdf) |
| 2025-10-15 | [Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e722d9-8a7c-4f96-b9f0-64c180541e3e.pdf) |
| 2025-07-19 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92cddd9-9e67-4ead-aa2d-57387d8e9e77.pdf) |
| 2025-04-25 | [Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8261f937-8244-470c-8f32-4276fdada835.pdf) |
| 2025-01-21 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7fb0245-6b96-4f35-b63a-1133007b5298.pdf) |
| 2024-10-19 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa08db5c-c93f-432d-84c7-dbfe8b2bcc4f.pdf) |
| 2024-10-19 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 - (Readable)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0ed1646-8737-4369-b77b-7d6fb3039f9c.pdf) |
| 2024-07-20 | [Board Meeting Outcome For Outcome Of Board Meeting Held On July 20, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25e9d5da-3199-40e9-83de-1a1812b72c78.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Rossari approved FY26 audited results, 25% final dividend, appointed independent director, allotted 8,250 ESOP shares, set up R&D facility. | [Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2026. 9h - Rossari approved FY26 audited results, 25% final dividend, appointed independent director, allotted 8,250 ESOP shares, set up R&D facility.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e0c2fbda-3591-44be-95a0-87a2ab324d48.pdf) |
| 9h - Of allotment of 8250 Equity shares under Rossari Employee Stock Option Plan - 2019. | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 9h - Of allotment of 8250 Equity shares under Rossari Employee Stock Option Plan - 2019.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4e420b9b-77d1-4516-9e6a-db1010686cb5.pdf) |
| 8h - FY26 audited results approved; 25% dividend, 8,250 ESOP shares, new Navi Mumbai R&D facility, capacity project rescheduled. | [Announcement under Regulation 30 (LODR)-Change in Directorate 8h - FY26 audited results approved; 25% dividend, 8,250 ESOP shares, new Navi Mumbai R&D facility, capacity project rescheduled.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/075106bd-9dcb-47c5-ab4d-8bc85f974880.pdf) |
| 8h - Approved FY26 audited results, 25% dividend, new independent director, 8,250 ESOP shares, Navi Mumbai R&D facility. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015. 8h - Approved FY26 audited results, 25% dividend, new independent director, 8,250 ESOP shares, Navi Mumbai R&D facility.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/be6cfb80-15af-460a-8037-35f9a8fe291a.pdf) |
| 5h - Rossari subsidiaries Unitop and Tristar reschedule capacity expansion into phased execution over next two years. | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015. 5h - Rossari subsidiaries Unitop and Tristar reschedule capacity expansion into phased execution over next two years.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/690b5094-593e-4ebe-a654-f19a65a89e67.pdf) |
| 4h - Q4 FY26 earnings conference call scheduled for April 28, 2026 at 5:00 PM IST. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4h - Q4 FY26 earnings conference call scheduled for April 28, 2026 at 5:00 PM IST.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5c748c71-da43-4698-852e-9d33fd0c126c.pdf) |
| 4 May - Of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 May - Of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c378823-f001-4635-bf0e-d7b52bf3e703.pdf) |
| 4 May - Of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 May - Of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0c378823-f001-4635-bf0e-d7b52bf3e703.pdf) |
| 31 Mar - Unitop commissioned remaining 15,000 MTPA ethoxylation capacity; total 66,000 MTPA effective March 31, 2026. | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 31 Mar - Unitop commissioned remaining 15,000 MTPA ethoxylation capacity; total 66,000 MTPA effective March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43629185-5a8c-4728-ba95-b4d5e68fc886.pdf) |
| 3 Apr - Unitop Chemicals to sell Saki Naka office premises for about Rs. 10 crore by Q2 FY27. | [Announcement Under Regulation 30 Of SEBI (LODR), Regulation 2015. 3 Apr - Unitop Chemicals to sell Saki Naka office premises for about Rs. 10 crore by Q2 FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5fc826cf-8eeb-4bc3-a18c-3d1aaecb6932.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f0cdf44-cf80-48d0-8477-ed21db771d20.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88c4592b-31e1-430a-9427-651f06a4c811.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62886c53-801d-453c-8040-15ad2b831657.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/03a958eb-93a8-4b66-a5fc-51f9a206f696.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e817dc3-1737-4f6e-82e1-e8c573f5d0c9.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e5e3d388-a15c-498b-9427-5418b7252be6.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d96ddf06-d3a0-4cdf-ae1c-985798225f79.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/854680f7-1791-455a-9a1e-670b504660ef.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e806c2a7-b5b2-4924-a987-0937ef544d48.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09d45a5b-ddda-4f0c-8d04-692fc1d63370.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a42320d0-b89f-476a-9b6f-1c862c0a7a71.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bbd6418e-1741-4f32-b1a0-165841c70f85.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce6fb66a-7168-4e6e-b36f-2cb7760a0866.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:36:00.538Z.